Wegovy and the semaglutide molecule continue to be studied across a variety of chronic conditions
Common side effects include nausea, vomiting, diarrhea, and mild digestive discomfort, which typically decrease over time as your body adjusts to the medication
Some laboratory studies suggest GLP-1 may modulate inflammatory pathways relevant to psoriasis, including reducing pro-inflammatory cytokines such as tumour necrosis factor-alpha (TNF-) and interleukin-17 (IL-17)
Additionally, retatrutide is currently undergoing a phase 3 clinical trial expected to conclude in December 2025, which could further validate its efficacy and safety
Occasionally persists 2448 hours after the injection
Bruising occurs when blood vessels are disrupted during the injection process, leading to the leakage of blood beneath the skins surface